IRUS Total

The evaluation of positron emission tomography to assess pharmacodynamics and pahrmacokinetics of anti cancer drugs

File Description SizeFormat 
Gupta-N-2008-MD-Thesis.pdfThesis20.2 MBAdobe PDFView/Open
Title: The evaluation of positron emission tomography to assess pharmacodynamics and pahrmacokinetics of anti cancer drugs
Authors: Gupta, Nishi
Item Type: Thesis or dissertation
Abstract: Positron emission tomography (PET) is a non-invasive imaging technique that is emerging as a useful tool in the field of cancer medicine particularly in drug development. The purpose of this thesis has been to perform clinical studies using two different radiotracers, 5-[^V]fIuorouracil (5-['^F]FU) and 2-[''C]thymidine, to assess pharmacokinetic and pharmacodynamic parameters respectively, which were derived from PET imaging and to establish the contribution that PET can add to drug development, in vivo, in man. Aims: 1) Quantify the pharmacodynamic effects of cytotoxic agents in tumour and normal tissue using 2-["C]thymidine 2) Measure changes in tumour and normal tissue pharmacokinetics of 5-Fluorouracil in response to the modulating agents carbogen and nicotinamide or interferon 3) Assessment of blood flow change in tumour and normal tissue to carbogen and nicotinamide or interferon 4) Interpretation of PET data using novel analysis methods with modified Patlak and spectral analysis Methods: In the 5-['^]FU study, patients with metastatic gastrointestinal cancer underwent PET scanning at the start of 2 separate chemotherapy cycles. The 2nd scan was performed after the administration of carbogen and nicotinamide or interferon. In the 2-["C]thymidine study patients receiving chemotherapy were scanned before commencing chemotherapy, and 1 week after the 3''' cycle of chemotherapy. Patients also had conventional imaging before the start of and after 3 cycles of treatment. Findings: After carbogen and nicotinamide administration, 5-['^]FU uptake was increased in tumour, but not in normal tissue. Regional perfusion was elevated in tumours but decreased in kidneys after carbogen and nicotinamide. After interferon administration, there was an increase in 5-['^]FU retention in tumours, but no increase in uptake. Regional perfusion in tumour and normal tissue was unaltered by interferon. Retention of 2-["C]thymidine decreased in tumour in keeping with the results of conventional radiology, suggesting a pathological response, assessed in vivo, to chemotherapy.
Issue Date: Jun-2008
Date Awarded: Oct-2008
URI: http://hdl.handle.net/10044/1/40004
DOI: https://doi.org/10.25560/40004
Supervisor: Price, Pat
Aboagye, Eric
Department: Division of Surgery, Oncology, Reproductive Biology and Anaesthetics - Medicine, Hammersmith
Publisher: Imperial College London
Qualification Level: Doctoral
Qualification Name: Doctor of Medicine (MD)
Appears in Collections:Medicine PhD theses

Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.

Creative Commons